Underuse of Aspirin in Type 2 Diabetes Mellitus: Prevalence and Correlates of Therapy in Rural Canada
Articles » Scholarly, peer reviewed
Author/Creator
Jennifer A. Klinke
Jeffrey A. Johnson
Lisa M. Guirguis
Ellen L. Toth
T. K. Lee
Richard Z. Lewanczuk
Sumit R. Majumdar
Clinical Therapeutics, vol. 26, no. 3, March 2004, pp. 439-446
Description
Study found that only 23% of a study group was found to be using aspirin as part of a diabetic preventative therapy, leading researchers to believe that better promotion of the benefits of such therapy is needed.